The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV
2 other identifiers
interventional
24
1 country
1
Brief Summary
The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea and increase activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease
Started Aug 2011
Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 30, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedFirst Posted
Study publicly available on registry
November 23, 2011
CompletedNovember 23, 2011
November 1, 2011
3 months
September 30, 2011
November 22, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in BORG-Scale
Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea).
Change from pre (minute o) in BORG-scale at directly post intervention (minute 60)
Secondary Outcomes (1)
Change in residual volume
change from pre (minute 0) in residual volume at post (minute 60) intervention
Study Arms (2)
Conventional breathing therapy
EXPERIMENTALfirst: conventional breathing therapy, second: reflectory breathing therapy
Reflectory breathing therapy
EXPERIMENTALfirst: reflectory breathing therapy second: conventional breathing therapy
Interventions
Eligibility Criteria
You may qualify if:
- inpatient rehabilitation
- COPD (Gold stage III and IV)
You may not qualify if:
- severe exacerbation in the last four weeks
- acute infections
- fever
- neuritides
- severe osteoporosis
- skin disease
- manic depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Schön Klinik Berchtesgadener Landlead
- University of Osnabrueckcollaborator
Study Sites (1)
Schön Klinik Berchtesgadener Land
Schönau, Bavaria, 83471, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Klaus Kenn, Dr. med.
Schön Klinik Berchtesgadener Land
- PRINCIPAL INVESTIGATOR
Stella Seeberg
University of Osnabrueck
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head physician (department of pulmonology)
Study Record Dates
First Submitted
September 30, 2011
First Posted
November 23, 2011
Study Start
August 1, 2011
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
November 23, 2011
Record last verified: 2011-11